The Legal and Ethical Debate on Human Heritable Genome Editing (HHGE) in South Africa
By Jantina de Vries,
EthicsLab
| 11. 15. 2024
The conversation around human heritable genome editing (HHGE) in South Africa is marked by controversy and conflicting interpretations of the law. At the center of this debate lies a team of lawyers based at a South African university, who have long championed a highly liberal stance toward reproductive technologies, including HHGE. Their assertions, however, have raised significant concerns among South Africa’s legal, ethical, and scientific communities.
Is heritable human genome editing already legal in South Africa?
This team has made the controversial claim that HHGE is already legal in South Africa – a position that has gained significant national and international outrage in recent days. As a non-lawyer, I have struggled to make sense of their argument which seems highly technical. Let me try to explain what I think they are saying.
Their argument seems to hinge on a specific interpretation of the National Health Act, which prohibits genetic modification for the purposes of reproductive cloning. They seem to argue that the term "reproductive" in the law should be read to refer to the purpose of the genetic manipulation –...
Related Articles
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...